Medical Marijuana Inc's. Dixie Elixir's Brand Launching Its First THC/CBD Product: Dixie X Synergy
SAN DIEGO, April 16, 2013 (GLOBE NEWSWIRE) -- Medical Marijuana Inc. (OTC:MJNA), a leading hemp industry innovator, announced that its portfolio company, Red Dice Holdings, LLC brand Dixie Elixirs and Edibles, is launching Dixie X Synergy , its first hybrid THC/CBD extract line of health and wellness products.
"Dixie X Synergy combines the benefits of THC and CBD into a product line that is truly greater than the sum of its parts," said Tripp Keber, Managing Partner of Dixie Elixirs and Edibles. "Dixie X takes advantage of CBD's natural ability to mitigate certain effects of THC while accentuating THC's beneficial properties."
CBD, or cannabidiol, and THC, or tetrahydrocannabinol, are cannabinoids found in the cannabis plant. THC, while beneficial, is also the plant constituent commonly associated with marijuana's euphoric attributes. Cannabidiol is non-intoxicating and used more as a strong anxiety and stress reliever.
"Independent testing has shown that CBD/THC combinations have been found to increase test respondents' alertness levels while helping them manage their appetite," said Tamar Wise, Science Director of Dixie Elixirs and Edibles. "Participants reported many pleasurable, relaxing feelings as well."
The Dixie X Synergy 1:1 ratio of CBD and THC offers many benefits as an antioxidant, anti-inflammatory and anti-spasmodic solution. It can be used to treat chronic pain, reduce neurotoxicity and assist with neuropathic conditions. Ideal for daytime use, this new and improved formula also provides increased efficiency, duration and maximum medicinal effect.
"We identified a gap in the medical marijuana industry," said Keber. "And Dixie X Synergy fills that gap for people looking for pain relief."
Initially, the company will offer four different Dixie X Synergy products to consumers: 25mg Pain Relief Capsules, a 50mg Pain Relief Salve, and 100mg and 500mg Dew Drop Tinctures. Sales will begin in over 500 dispensaries in Colorado immediately, then expand to California, Arizona and Washington as the company's licensing agreements permit.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.
Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.
For more information, please visit the company's website at: www.MedicalMarijuanaInc.com
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE(These statements have not been evaluated by the Food and Drug Administration (FDA). These products and statements are not intended to diagnose, treat, cure, or prevent any disease.
CONTACT: Corporate Contact: Medical Marijuana, Inc. Toll Free: 888-OTC-MJNA (888-682-6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc Investor Relations Contact: Stuart T. Smith SmallCapVoice.Com, Inc. P. 512-267-2430 F. 512-267-2530 Email: email@example.com Skype (SPU): SmallCapVoice.com AIM: SmallCapVoice7Source: Medical Marijuana Inc 2013 GlobeNewswire, Inc.